201 related articles for article (PubMed ID: 2557688)
1. Selective inhibition of polymorphonuclear neutrophil activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Ackermann MF; Gasiewicz TA; Lamm KR; Germolec DR; Luster MI
Toxicol Appl Pharmacol; 1989 Dec; 101(3):470-80. PubMed ID: 2557688
[TBL] [Abstract][Full Text] [Related]
2. Acute myelotoxic responses in mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Luster MI; Hong LH; Boorman GA; Clark G; Hayes HT; Greenlee WF; Dold K; Tucker AN
Toxicol Appl Pharmacol; 1985 Oct; 81(1):156-65. PubMed ID: 2996177
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin is mediated by the aryl hydrocarbon (Ah) receptor complex.
Alsharif NZ; Lawson T; Stohs SJ
Toxicology; 1994 Sep; 92(1-3):39-51. PubMed ID: 7940568
[TBL] [Abstract][Full Text] [Related]
4. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression.
Kerkvliet NI; Steppan LB; Brauner JA; Deyo JA; Henderson MC; Tomar RS; Buhler DR
Toxicol Appl Pharmacol; 1990 Aug; 105(1):26-36. PubMed ID: 2168100
[TBL] [Abstract][Full Text] [Related]
5. Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated myelotoxicity by thyroid hormones.
Hong LH; McKinney JD; Luster MI
Biochem Pharmacol; 1987 Apr; 36(8):1361-5. PubMed ID: 3036167
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the murine Ah phenotype and the hepatic uptake and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Shen ES; Olson JR
Drug Metab Dispos; 1987; 15(5):653-60. PubMed ID: 2891482
[TBL] [Abstract][Full Text] [Related]
7. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah nonresponsive C57BL/6J mice.
Lin FH; Stohs SJ; Birnbaum LS; Clark G; Lucier GW; Goldstein JA
Toxicol Appl Pharmacol; 1991 Mar; 108(1):129-39. PubMed ID: 1672475
[TBL] [Abstract][Full Text] [Related]
8. Ah receptor in mice genetically "nonresponsive" for cytochrome P4501A1 induction: cytosolic Ah receptor, transformation to the nuclear binding state, and induction of aryl hydrocarbon hydroxylase by halogenated and nonhalogenated aromatic hydrocarbons in embryonic tissues and cells.
Harper PA; Golas CL; Okey AB
Mol Pharmacol; 1991 Nov; 40(5):818-26. PubMed ID: 1658612
[TBL] [Abstract][Full Text] [Related]
9. Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells.
Singh KP; Wyman A; Casado FL; Garrett RW; Gasiewicz TA
Carcinogenesis; 2009 Jan; 30(1):11-9. PubMed ID: 18820284
[TBL] [Abstract][Full Text] [Related]
10. The role of receptors in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) toxicity.
Dencker L
Arch Toxicol Suppl; 1985; 8():43-60. PubMed ID: 3006634
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the mechanism of action of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decrease of nuclear estrogen receptor levels in wild-type and mutant mouse Hepa 1c1c7 cells.
Zacharewski T; Harris M; Safe S
Biochem Pharmacol; 1991 Jun; 41(12):1931-9. PubMed ID: 1645554
[TBL] [Abstract][Full Text] [Related]
12. Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor.
Lin FH; Clark G; Birnbaum LS; Lucier GW; Goldstein JA
Mol Pharmacol; 1991 Mar; 39(3):307-13. PubMed ID: 1848654
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of 2,3,7,8-tetrachlorodibenzo-p-dioxin induced endotoxin hypersensitivity: association with hepatotoxicity.
Rosenthal GJ; Lebetkin E; Thigpen JE; Wilson R; Tucker AN; Luster MI
Toxicology; 1989 Jun; 56(3):239-51. PubMed ID: 2472021
[TBL] [Abstract][Full Text] [Related]
14. Enhanced suppression of humoral immunity in DBA/2 mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Morris DL; Snyder NK; Gokani V; Blair RE; Holsapple MP
Toxicol Appl Pharmacol; 1992 Jan; 112(1):128-32. PubMed ID: 1310164
[TBL] [Abstract][Full Text] [Related]
15. Fetal thymus organ culture as an in vitro model for the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners.
Dencker L; Hassoun E; d'Argy R; Alm G
Mol Pharmacol; 1985 Jan; 27(1):133-40. PubMed ID: 3965925
[TBL] [Abstract][Full Text] [Related]
16. Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methylcholanthrene.
Okey AB; Vella LM; Harper PA
Mol Pharmacol; 1989 Jun; 35(6):823-30. PubMed ID: 2543914
[TBL] [Abstract][Full Text] [Related]
17. Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium.
Greenlee WF; Dold KM; Irons RD; Osborne R
Toxicol Appl Pharmacol; 1985 Jun; 79(1):112-20. PubMed ID: 2996175
[TBL] [Abstract][Full Text] [Related]
18. 1-amino-3,7,8-trichlorodibenzo-p-dioxin: a specific antagonist for TCDD-induced myelotoxicity.
Luster MI; Hong LH; Osborne R; Blank JA; Clark G; Silver MT; Boorman GA; Greenlee WF
Biochem Biophys Res Commun; 1986 Sep; 139(2):747-56. PubMed ID: 3021141
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity to suppression of cytotoxic T cell generation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on the Ah genotype of the murine host.
Nagarkatti PS; Sweeney GD; Gauldie J; Clark DA
Toxicol Appl Pharmacol; 1984 Jan; 72(1):169-76. PubMed ID: 6608808
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated hepatotoxicity in C57BL/6J and DBA/2J mice.
Shen ES; Gutman SI; Olson JR
J Toxicol Environ Health; 1991 Apr; 32(4):367-81. PubMed ID: 2016751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
